Francisco Silveira Guimaraes
Francisco Silveira Guimaraes
Afiliação Department of Pharmacology, School of Medicine of Ribeirão Preto, USP, Brazil
Verified email at
Cited by
Cited by
Role of 5-HT in anxiety, stress and depression
FG Graeff, FS Guimarães, TGC Andrade, JFW Deakin
Pharmacol. Biochem. Behav 54, 129-141, 1996
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
AW Zuardi, J Crippa, JEC Hallak, FA Moreira, FS Guimaraes
Brazilian journal of medical and biological research 39, 421-429, 2006
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
AC Campos, FA Moreira, FV Gomes, EA Del Bel, FS Guimaraes
Philosophical Transactions of the Royal Society B: Biological Sciences 367 …, 2012
Animal models of anxiety disorders and stress
AC Campos, MV Fogaça, DC Aguiar, FS Guimaraes
Brazilian Journal of Psychiatry 35, S101-S111, 2013
Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
AC Campos, FS Guimarães
Psychopharmacology 199 (2), 223-230, 2008
Effects of ipsapirone and cannabidiol on human experimental anxiety
AW Zuardi, RA Cosme, FG Graeff, FS Guimaraes
Journal of Psychopharmacology 7 (1_suppl), 82-88, 1993
Antidepressant‐like effects of cannabidiol in mice: possible involvement of 5‐HT1A receptors
TV Zanelati, C Biojone, FA Moreira, FS Guimarães, SRL Joca
British journal of pharmacology 159 (1), 122-128, 2010
Antianxiety effect of cannabidiol in the elevated plus-maze
FS Guimarães, TM Chiaretti, FG Graeff, AW Zuardi
Psychopharmacology 100 (4), 558-559, 1990
Antipsychotic effect of cannabidiol.
AW Zuardi, SL Morais, FS Guimaraes, R Mechoulam
The Journal of clinical psychiatry, 1995
5‐HT1A receptors are involved in the cannabidiol‐induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
LBM Resstel, RF Tavares, SFS Lisboa, SRL Joca, FMA Corrêa, ...
British journal of pharmacology 156 (1), 181-188, 2009
Cannabidiol, neuroprotection and neuropsychiatric disorders
AC Campos, MV Fogaça, AB Sonego, FS Guimarães
Pharmacological research 112, 119-127, 2016
Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects
SRL Joca, FS Guimarães
Psychopharmacology 185 (3), 298-305, 2006
Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice
FA Moreira, FS Guimarães
European journal of pharmacology 512 (2-3), 199-205, 2005
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
AC Campos, Z Ortega, J Palazuelos, MV Fogaça, DC Aguiar, ...
International Journal of Neuropsychopharmacology 16 (6), 1407-1419, 2013
A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
AW Zuardi, JA Crippa, JE Hallak, S Bhattacharyya, Z Atakan, ...
Curr Pharm Des 18 (32), 5131-5140, 2012
Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test
FA Moreira, DC Aguiar, FS Guimarães
Progress in Neuro-Psychopharmacology and Biological Psychiatry 30 (8), 1466-1471, 2006
Estresse, depressão e hipocampo
SRL Joca, CM Padovan, FS Guimarães
Brazilian Journal of Psychiatry 25, 46-51, 2003
Regional gray matter abnormalities in panic disorder: a voxel-based morphometry study
RR Uchida, CM Del-Ben, GF Busatto, FLS Duran, FS Guimarães, ...
Psychiatry Research: Neuroimaging 163 (1), 21-29, 2008
Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey, Psychopharm. 103 (1991)
FS Guimarães, AP Carobrez, JC De Aguiar, FG Graeff
Full Text via CrossRef| View Record in Scopus| Cited By in Scopus (85), 91-94, 0
Modulation of stress consequences by hippocampal monoaminergic, glutamatergic and nitrergic neurotransmitter systems
SRL Joca, FR Ferreira, FS Guimarães
Stress 10 (3), 227-249, 2007
The system can't perform the operation now. Try again later.
Articles 1–20